Bio-Reference Labs (BRLI) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Price: $4.70 --0%
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Financial Fact:
Depreciation and Amortization: 5.09M
Today's EPS Names:
ZVOI, SYRS, ATRA, More
Join SI Premium – FREE
Bio-Reference Labs (NASDAQ: BRLI) reported Q2 EPS of $0.37, $0.05 better than the analyst estimate of $0.32. Revenue for the quarter came in at $201.4 thousand versus the consensus estimate of $195.64 thousand.
For earnings history and earnings-related data on Bio-Reference Labs (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- H.C. Wainwright Reiterates Buy Rating on Strategy (MSTR)
- TFS Financial (TFSL) Reports In-Line Q4 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
